Dark

Check out our API

ANCN
Anchiano Therapeutics Ltd.
stock NASDAQ

Inactive

Mar 16, 2021

75.36USD+5.369%(+3.84)1,564,848

Pre-market

0.00USD-100.000%(-71.52)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Mar 16, 2021

10:36AM EDT Mid-Morning Market Update: Markets Mixed; Jabil Beats Q2 Views Benzinga

08:17AM EDT The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study Benzinga

Mar 15, 2021

05:54PM EDT Anchiano Announces Shareholder Approval of the Merger with GlobeNewswire Inc

Mar 8, 2021

02:38PM EST Mid-Afternoon Market Update: Nasdaq Drops Over 150 Points; Crude Oil Down 2% Benzinga

12:03PM EST Mid-Day Market Update: Dow Jumps 500 Points; AnaptysBio Shares Plunge Benzinga

10:21AM EST Shares of Anchiano Therapeutics Ltd. (ANCN) are surging over 100% on Monday morning despite no press releases or SEC filings from the company. RTTNews

10:14AM EST Mid-Morning Market Update: Markets Gain; US Senate Clears $1.9 Trillion Covid-19 Relief Bill Benzinga

Feb 18, 2021

03:19PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds CNIG, CHNG, CATM, and ANCN Shareholders PR Newswire

Feb 11, 2021

02:55PM EST Mid-Afternoon Market Update: Wall Street Stocks Tumble; Crude Oil Down Over 1% Benzinga

02:03PM EST Mid-Day Market Update: Biden Holds Talks With Xi; Pepsi Reports Upbeat Q4 Benzinga

11:26AM EST Mid-Morning Market Update: RCM Technologies Shares Spike Higher, Even As Walt Disney Prepares to Announce Q1 Results Benzinga

Feb 9, 2021

03:43PM EST ANCHIANO INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick PR Newswire

Feb 4, 2021

03:17PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds CHNG, CPAH, CATM, and ANCN Shareholders PR Newswire

Jan 28, 2021

05:31PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds CPAH, CATM, ANCN and GNBF Shareholders PR Newswire

Jan 26, 2021

02:59PM EST SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of GlobeNewswire Inc

Jan 21, 2021

03:22PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds CPAH, CATM, ANCN and GNBF Shareholders PR Newswire

01:58PM EST SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of GlobeNewswire Inc

Jan 16, 2021

11:12AM EST ANCHIANO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Anchiano Therapeutics Ltd. - ANCN Business Wire

Jan 13, 2021

06:25PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds CHNG, CPAH, CATM, and ANCN Shareholders PR Newswire

04:13PM EST SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of PR Newswire

Jan 6, 2021

04:34PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds ANCN, PRVL, WORK, and GNBF Shareholders PR Newswire

Dec 24, 2020

11:49PM EST Lifshitz Law Firm, P.C. Announces Investigation of ANCN, BEAT, HMSY, SNCA, PR Newswire

Dec 22, 2020

07:11PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds ANCN, PRVL, BRPA, and TPGY Shareholders PR Newswire

Dec 21, 2020

11:00AM EST Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies: GlobeNewswire Inc

Dec 17, 2020

10:36AM EST SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation GlobeNewswire Inc

Dec 16, 2020

07:15AM EST The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal Benzinga

Dec 15, 2020

05:16PM EST SHAREHOLDER ALERT: WeissLaw LLP Investigates Anchiano Therapeutics Ltd. PR Newswire

10:05AM EST Shares of nano-cap company Anchiano Therapeutics Ltd. (ANCN) are currently soaring 130% after the preclinical biopharmaceutical company announced a merger deal with clinical-stage biotech company Chemomab Ltd. RTTNews

09:11AM EST Anchiano Therapeutics And Chemomab Enter Definitive Merger Agreement RTTNews

09:02AM EST Anchiano Therapeutics And Chemomab Announce Entry Into Definitive Merger Agreement; Chemomab Shareholders To Convert 100% Of Existing Equities Into Securities Of Combined Co. Benzinga

09:00AM EST Merger brings lead compound CM-101, a first in class anti-CCL24 antibody into advanced clinical development for fibrosis-related diseases with significant unmet medical need GlobeNewswire Inc

Nov 6, 2020

07:47AM EST The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold Benzinga

Oct 21, 2020

08:04AM EDT The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings Benzinga

Oct 20, 2020

03:55PM EDT Anchiano Therapeutics Appoints Neil Cohen As CEO Effective Immediately Benzinga

Share